According to latest report, the U.S.
roadside drug testing market size was USD 1.45 billion in 2023,
calculated at USD 1.52 billion in 2024 and is expected to reach around USD 2.28
billion by 2033, expanding at a CAGR of 4.65% from 2024 to 2033.
The Complete Study is Now Available for Immediate Access
| Download the Sample Pages of this Report@ https://www.novaoneadvisor.com/report/sample/8919
U.S. Roadside Drug Testing Market Key Takeaways:
• Alcohol segment dominated the market with a share of
31.96% in 2023.
• On the other hand, cannabis/marijuana segment is expected
to grow at the highest CAGR of 5.50% over the forecast period.
• Breath segment dominated the market with a share of 44.44%
in 2023.
• Highway police segment dominated the market with a share
of 90.87% in 2023.
The market growth is attributed to factors such as rising
drug use, especially with the legalization of marijuana in many countries and
increasing awareness of the danger of drug-impaired driving. To ensure public
safety, law enforcement agencies are investing in new technologies for
efficient and accurate testing.
The U.S. roadside drug testing market deals with analyzing
biological samples, such as urine, blood, and hair. Devices are used to detect
the presence of drugs or their metabolites in a person’s body. The widely used
testing portfolio of alcohol and drugs includes laboratory tests, visual-read
screening tools, and immunoassay components. In addition, government campaigns
and regulations against impaired driving are enhancing the demand for roadside
testing solutions.
The market growth is also driven by rapid technological
advancements, allowing effective and quicker detection of various substances.
The rise in accidents and fatalities in the U.S. related to substance and
alcohol abuse among drivers has become a significant public safety concern.
In the U.S., the increasing prevalence of substance abuse is
anticipated to a marked increase in drug-impaired driving cases. The number of
traffic fatalities for alcohol-impaired drivers has remained persistently high
accounting for nearly 30% of all traffic-related deaths, according to the
National Highway Traffic Safety Administration (NHTSA). In addition, the rise
in the use of illicit drugs, recreational marijuana, and prescription
medications has aggravated the problem, owing to a concerning growth in
drug-related fatalities and accidents.
To invest in more sophisticated testing tools, the rising
prevalence of drug impact and use on driving safety has prompted federal and
state authorities. Strict regulations and public awareness campaigns have
further enhanced the need for these testing solutions.
Immediate Delivery is Available | Get Full Report
Access@ https://www.novaoneadvisor.com/report/checkout/8919
U.S. Roadside Drug Testing Market Trends
• The increasing demand for alcohol testing devices for
alcohol and drugs contributed to propelling the market growth.
• The rising integration of artificial intelligence into
these devices, reducing human error and enhancing their accuracy further
enhances the market growth.
• The expansion of law enforcement programs and rising
continuous advancements in testing technology are further anticipated to drive
the growth of the roadside drug testing market in the U.S.
U.S. Roadside Drug Testing Market Segment Insights
Drug type insights
Alcohol segment dominated the market with a share of 31.96%
in 2023. The segment growth is driven by the widespread use of standardized
testing devices such as breathalyzers and alcohol impairment is a
well-developed concern with developed legal limits. The effects of alcohol on
driving ability are comprehensively studied and make it easier to set
impairment thresholds and enforce regulations. Furthermore, alcohol is the
major consumed substance, owing to a higher frequency of testing. The developed
protocols and infrastructure for alcohol testing, with the drunk driving laws’s
public awareness, are expected to drive the segment growth in the market.
In addition, the marijuana or cannabis segment is expected
to grow fastest during the forecast period.
By sample types
Breath segment dominated the market with a share of 44.44%
in 2023. The most commonly used method in roadside drug testing is breath
samples due to their immediate results, ono-invasive nature, and practicality.
Law enforcement researchers favor breath tests due to their easy and quick
administer during traffic stops, reducing the disruption for both the officer
and the driver. The device, breathalyzers is used to measure alcohol levels,
and have been well-developed and widely accepted in the legal system, providing
a standardized and reliable method for detecting alcohol impairment.
Breath-based testing is expanding beyond alcohol with the
advancement of technology to detect certain drugs. These certain drugs are in
development compared to blood or saliva tests. The ability of breath tests to
deliver quick results makes them an ideal tool and simplicity which requires no
specialized training to administer for roadside screening.
In addition, as compared to urine or blood tests, breath
tests are less intrusive, owing to higher compliance from drivers. These
factors, tailored with the legal framework supporting breathalyzer use, have
made breath samples the most important method in roadside alcohol and drug
testing, guaranteeing road safety by allowing law enforcement to swiftly
address and identify impaired driving.
By test location types
Highway police segment dominated the market with a share of
91.0% in 2023. The highway police segment growth is driven by ensuring road
safety and is primarily responsible for enforcing traffic laws. Their
jurisdiction over major roads and highways, where a significant proportion of
traffic cases occurs gives them a major role in deterring and monitoring
impaired driving. Combined with specialized tools and training, highway police
operate sobriety checkpoints and conduct routine checks, making them major players
in enforcement and testing.
In addition, highway police are combined with specialized
resources and training to balance drug testing and make them the primary users
of these technologies. The adoption of drug testing into their routine
processes helps address and identify impaired drivers rapidly. As a result,
highway police notably enhance product development and market trends, ensuring
that testing solutions address their particular needs for ease of use,
reliability, and accuracy. The dominance of highway police in the market
reflects their major role in enhancing overall traffic safety and combating
drug-impaired driving.
State Insights
California Roadside Drug Testing Market Trends
California roadside drug testing market dominated with
largest revenue share of 14.58% in 2023. The state generated the highest
revenue due to its large population, significant number of roadways, and
progressive stance on drug regulations. As the most populous state, California
has a high volume of traffic, increasing the demand for effective roadside drug
testing to ensure road safety. The state’s comprehensive approach to drug
enforcement, including strict DUI laws and widespread implementation of drug
testing, further drives market demand. Additionally, California’s progressive
policies on drug legalization, such as the legalization of recreational
marijuana, have heightened the need for reliable roadside testing to address
the complexities of impaired driving. The state’s large budget for law
enforcement and public safety also supports the adoption of advanced drug
testing technologies. Consequently, California’s unique combination of factors
makes it a key player and major influence in the market.
California roadside drug testing market is expected to grow
over the forecast period. Advancements in portable drug testing devices,
utilizing advanced chromatographic techniques, have enhanced real-time
detection capabilities. These devices allow for swift and accurate substance
analysis, supporting law enforcement in making prompt decisions. The continuous
improvement of these technologies reflects the evolving challenges in
addressing impaired driving across federal and municipal levels.
Texas Roadside Drug Testing Market Trends
The roadside drug testing market in Texas is growing at a
lucrative growth rate. Texas has seen a rise in drug-related issues and
enforcement challenges, particularly with the legalization of marijuana in
neighboring states, which further fuels the need for accurate and efficient
testing methods. The state’s commitment to public safety and its substantial
law enforcement budget also support the widespread adoption of advanced
roadside drug testing technologies.
New York Roadside Drug Testing Market Trends
New York roadside drug testing market is expected to grow
over the forecast period.New York has emerged as one of the leading state in
the U.S. in implementing and refining roadside drug testing policies. The
state’s proactive approach to addressing the issue of drug-impaired driving has
driven significant advancements in the development and deployment of roadside
drug testing technology. A key factor contributing to New York’s leadership in
this domain is the state’s high rate of drug-related traffic fatalities. The
alarming statistics on drug-impaired driving incidents are encouraging
policymakers to prioritize the development of effective countermeasures. By
investing in R&D, New York has been at the forefront of testing &
validating new drug testing devices and methodologies.
U.S. Roadside Drug Testing Market Company Insights
Some of the major players operating in the U.S. roadside
drug testing market in the U.S. such as PAS Systems International, AK
GlobalTech Corp, Alcohol Countermeasure Systems Corp., CMI Inc., Immunalysis
Corporation, Hound Labs, Inc., Lifeloc Technologies, Inc., Intoximeters,
Abbott, Drägerwerk AG & Co. KGaA and others. These major players are
operating strategies such as providing extensive training for law enforcement,
accurate testing devices, partnerships, collaborations, mergers and
acquisitions, product launches, and developing portable.
Major market players such as Abbott and Drager on strategic
partnerships and advanced technology integration with law enforcement agencies.
For instance, Abbott’s SoToxa and Dräger’s Drug Test 5000 are widely used to
guarantee efficient and reliable roadside drug screening, reducing impaired
driving incidents and enhancing road safety.
Buy Now Full Report: https://www.novaoneadvisor.com/report/checkout/8919
Some of the prominent players in the U.S. roadside drug
testing market include:
•Drägerwerk AG & Co. KGaA
•Abbott.
•Intoximeters
•Lifeloc Technologies, Inc.
•Hound Labs, Inc.
•Immunalysis Corporation
•CMI Inc.
•Alcohol Countermeasure Systems Corp.
•AK GlobalTech Corp.
•PAS Systems International, Inc
U.S. Roadside Drug Testing Market Recent Developments
• In May 2024, on-site demonstrations of the HOUND CANNABIS
BREATHALYZER1 were conducted by Hound Labs, Inc. They engaged with
professionals, employers, and clinics in legal, and human resources and
discussed the implementation of recent-use breath testing to improve drug
testing program outcomes.
• In November 2023, Minnesota launched a pilot project
studying roadside impairment tests. The aim behind this launch was to determine
if someone is under the influence of drugs while driving.
• In September 2024, the new roadside drug wipes were
officially launched by PSNI. These drug wipes will be used in addition to
existing testing available for alcohol levels.
Segments Covered in the Report
This report forecasts revenue growth at country levels and
provides an analysis of the latest industry trends in each of the sub-segments
from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the
U.S. roadside drug testing market
By Drug
• Alcohol
• Cannabis/Marijuana
• Cocaine
• Opioids
• Amphetamine & Methamphetamine
• LSD
• Others
By Sample
• Saliva
• Breath
• Urine
• Blood
Test Location
• Highway Police
• Drug Enforcement Agencies
By States
• Alabama
• Alaska
• Arizona
• Arkansas
• California
• Colorado
• Connecticut
• Delaware
• Florida
• Georgia
• Hawaii
• Idaho
• Illinois
• Indiana
• Iowa
• Kansas
• Kentucky
• Louisiana
• Maine
• Maryland
• Massachusetts
• Michigan
• Minnesota
• Mississippi
• Missouri
• Montana
• Nebraska
• Nevada
• New Hampshire
• New Jersey
• New Mexico
• New York
• North Carolina
• North Dakota
• Ohio
• Oklahoma
• Oregon
• Pennsylvania
• Rhode Island
• South Carolina
• South Dakota
• Tennessee
• Texas
• Utah
• Vermont
• Virginia
• Washington
• West Virginia
• Wisconsin
• Wyoming
Immediate Delivery Available, Get Full Access@ https://www.novaoneadvisor.com/report/checkout/8919
USA : +1 804 441 9344
APAC : +61 485 981 310 or +91 87933 22019
Europe : +44 7383 092 044
Email: sales@novaoneadvisor.com
Web: https://www.novaoneadvisor.com/
You can place an order or ask any questions, please feel
free to contact at sales@novaoneadvisor.com|
+1 804 441 9344
